Australian researchers have called for paediatric formulations for ADHD medications after new figures show a large proportion of poisonings occurred from a medication that is only available in adult doses.

The researchers found that more than 17,000 exposures to ADHD medications were reported to the NSW Poisons Information Centre between 2014 and 2023.

Poisoning exposures to ADHD medications have grown 16.5% each year in that period, with more than 3000 exposures reported in 2023 compared with 795 in 2014.

More than half (56%) of all cases were either referred to hospital or already in hospital when the notification was made. Overall, 38.5% of exposures were intentional, mainly due to deliberate self-poisoning, the researchers said.

Among the six medications used to treat ADHD, clonidine and methylphenidate were the most commonly linked to poisoning, each causing 35% of reports.

“Poisoning exposures to ADHD medications present a growing public health issue,” the researchers said in the Australian & New Zealand Journal of Psychiatry .